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Tar DNA binding protein 43 (TDP-43) has 
emerged as a key player in many neurodegenerative 
pathologies including frontotemporal lobar 
degeneration (FTLD) and amyotrophic lateral 
sclerosis (ALS). Hallmarks of both FTLD and ALS 
are the toxic cytoplasmic inclusions of the prion-
like C-terminal fragments of TDP-43 (TDP-43 
CTD), formed upon proteolytic cleavage of full-
length TDP-43 in the nucleus and subsequent 
transport to the cytoplasm. Both full-length TDP-
43 and its CTD are also known to form stress 
granules (SGs) by coacervating with RNA in the 
cytoplasm during stress and may be involved in 
these pathologies. Furthermore, mutations in PGRN 
gene, leading to haploinsufficiency and diminished 
function of progranulin (PGRN) protein, are 
strongly linked to FTLD and ALS. Recent reports 
have indicated that proteolytic processing of PGRN 
to smaller protein modules called granulins (GRNs) 
contributes to FTLD and ALS progression, with 
specific GRNs exacerbating TDP-43–induced 
cytotoxicity. Here, we investigated the interactions 
between the proteolytic products of both TDP-43 
and PGRN. Based on structural disorder and charge 
distributions, we hypothesized that GRNs -3 and -5 
could interact with TDP-43 CTD. We also show 
that in both reducing and oxidizing conditions 
GRNs -3 and -5 interact with and differentially 
modulate TDP-43 CTD aggregation and/or liquid-
liquid phase separation (LLPS) in vitro. While 
GRN-3 promoted insoluble aggregates of TDP-43 
CTD, GRN-5 mediated LLPS. These results 
constitute the first observation of an interaction 
between GRNs and TDP-43, suggesting a 
mechanism by which attenuated PGRN function 
could lead to familial FTLD or ALS. 
  
INTRODUCTION 
Frontotemporal lobar degeneration (FTLD) is a 
neurodegenerative disorder characterized by 
progressive changes in behavior, speech, and 
personality among elderly patients (1,2). These 
changes are bought upon by a gradual atrophy of 
the frontal and anterior temporal lobes of the brain  
(3-6). Based on histopathology, heritable FTLD can 
be classified into the following subtypes: FTLD-
TDP form, which is characterized by the presence 
of cytoplasmic inclusions of TAR DNA binding 
protein-43 (TDP-43), and which constitutes about 
half of all cases of FTLD (7); FTLD-Tau in which 
cytoplasmic inclusions of hyperphosphorylated tau 
are observed, and FTLD-FUS, which is associated 
with inclusions of an RNA-binding protein called 
fused in sarcoma (FUS) (8-12). The FTLD-TDP 
pathology is further sub-classified based on genetic 
and clinical presentation (13). Autosomal dominant 
mutations to progranulin gene (PGRN) are 
associated with type A while the hexanucleotide 
repeat expansions in C9orf72 are present in type B 
cases (13). Inclusions of TDP-43 are also observed 
in patients with ALS (14-16). In addition to 
mutations in TDP-43, those in several genes have 
been linked to ALS including FUS, superoxide 
dismutase 1 (SOD1) and hexanucleotide repeat 
expansions in C9orf72. Since TDP-43-based 
neuropathology is present in ~50% of FTLD and 
~97% of ALS cases (17), the protein represents a 
molecular link connecting these neurodegenerative 
diseases as a clinicopathological spectrum of the 
proteinopathies (15,18-20). It has also come to light 
that TDP-43 may contribute to the pathogenesis of 
Alzheimer disease (AD) via both β-amyloid (Aβ) 
dependent and independent pathways (21). 
Furthermore, TDP-43 abnormalities have also been 
associated with traumatic brain injury (chronic 
traumatic encephalopathy) in both pre-clinical and 
clinical studies (7), and observed in cognitively 
impaired persons in advanced age with 
hippocampal sclerosis, Huntington's disease and 
some other maladies (22). Due to the widespread 
prevalence of TDP-43 in neurodegenerative 
pathogenesis, all abnormalities involving the 
protein are classified into the category of ‘TDP-43 
proteinopathies’ (22,23). 
TDP-43 is a member of the heterogenous 
ribonucleoprotein family involved in 
transcriptional regulation and mRNA splicing in 
neurons (24). The protein consists of an N-terminal 
domain, two RNA recognition motifs (RRMs) 
followed by a low-complexity, glycine-rich C-
terminal domain (25). The protein is known to 
dimerize through the N-terminal domain, while 
specific phosphomimic mutants within this domain 
disrupt its aggregation, liquid-liquid phase 
separation (LLPS) and RNA splicing activity 
(26,27). Although mainly localized in the nucleus, 
in the diseased state, a fraction of the full-length 
TDP-43 is proteolytically cleaved and thus 
generated 25 and 35 kDa (C25 and C35) C-terminal 
fragments are transported into the cytoplasm. These 
fragments form toxic insoluble inclusions observed 
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in ALS and FTLD-TDP patients (19,28,29). Under 
stress, both full-length and TDP-43 C-terminal 
fragments are also known to bind RNA and 
translocate to the cytosol, where they undergo 
LLPS to form the membraneless organelles called 
stress granules (29). LLPS has been increasingly 
observed in many cellular systems and are thought 
to be important in modulating many cellular 
functions (30-39). The precise mechanism of stress 
granule dynamics in TDP-43 pathophysiology 
remains unclear but many proteins are known to 
interact with, and partition into the phase separated 
droplets of TDP-43 (40,41). In FTLD and ALS, the 
aberrant LLPS of TDP-43 has emerged as a driving 
factor for the aggregation of the protein (40,42,43).   
Progranulin (PGRN) is a 63.5 kDa secreted 
protein expressed in many cells including the 
neurons and in microglia (44-46), with pleiotropic 
roles in both physiological and pathological 
processes (47-51). The protein consists of seven 
and a half cysteine-rich modules called granulins 
(GRNs) (Fig 1a) (47,49,52-54), which are 
generated by proteolytic processing of PGRN by 
many proteases. PGRN and GRNs are observed to 
co-exist in vivo with opposing inflammatory 
functions (55). In FTLD, the observed inclusions of 
TDP-43 C-terminal fragments  occur in the genetic 
backdrop of autosomal dominant, heterozygous 
mutations of PGRN that leads to haploinsuffiency 
of the PGRN protein. Homozygous PGRN 
mutations on the other hand lead to neuronal ceroid 
lipofuscinosis (NCL), a lysosomal storage disease 
(56). The production of GRNs in haploinsufficient, 
but not the null state in FTLD, suggests that they 
are key players in the disease phenotypes. This also 
indicates that the extenuation of PGRN function 
could arise from its increased proteolytic 
processing to generate GRNs (55). Indeed, GRNs 
are shown to interact with TDP-43 and exacerbate 
latter’s levels and toxicity in C.elegans, 
establishing that PGRN cleavage to GRNs could 
represent an important part of the disease process in 
FTLD (57). Despite the growing evidence on the 
involvement of GRNs, their precise mechanisms in 
FTLD and related pathologies remain unclear. In 
this report, we sought to understand the interactions 
between GRNs and TDP-43 CTD, both of which 
are proteolytic products of their precursors, under 
reducing and oxidizing conditions in vitro. Our 
premise for investigations under reducing and 
oxidizing conditions stems from our previous 
observation that GRN-3 is active in both reduced 
and oxidized forms (58,59). Furthermore, GRNs’ 
presence in both extra- and intracellular space led 
us to hypothesize that they may play a role under 
redox fluctuations. Here, we specifically 
investigated whether GRNs -3 and -5 are able to 
modulate LLPS or formation of insoluble 
inclusions of TDP-43 CTD, which shed insights 




Structural disorder and charge distribution 
among GRNs and TDP-43 CTD suggest potential 
interactions. The 14.5 kDa construct of TDP-43 
that constitutes residues 267-414 in the C-terminal 
domain (TDP-43 CTD) is a major part of the C25 
proteolysis fragment that forms aberrant inclusions 
within the cytosol in FTLD and ALS patients (Fig 
1a)(16). Fig 1b shows that TDP-43 CTD is largely 
disordered, and previous study indicated that this 
protein contains sequence of low-complexity that is 
involved in LLPS (60). On the other hand, GRNs 
(1-7) are small ~ 6 kDa proteins with the conserved 
sequence; X2-3CX5-6CX5CCX8CCX6 
CCXDXXHCCPX4CX5-6CX (Fig 1a). The 12 
conserved cysteine residues form six putative 
intramolecular disulfide bonds (61) (Fig 1a). Fig 1c 
and Fig 1d show that despite the fact that these 
proteins contain high levels of cysteine, which is 
the strongest order-promoting residue, GRN-3 and 
GRN-5 are predicted to be characterized by high 
levels of disorder. This is in line with the results of 
our previous studies, where we have shown that 
under reducing conditions, GRN-3 is fully 
disordered while in the oxidizing conditions, the 
protein obtains thermal stability via disulfide bonds 
without significant gain in the overall structure 
(59,62). 
As a first step in understanding the effect of 
GRNs on TDP-43, here we report the interactions 
of GRNs 3 and 5 with TDP-43 CTD in both 
reducing and oxidizing conditions. GRN-5 was 
expressed and purified using the established 
method for GRN-3 (59) with some minor 
modifications (see Experimental Procedures). As 
observed previously with GRN-3 (59,62), we 
observed that GRN-5 too, in both reducing and 
oxidizing conditions, show a random coil 
disordered structure (Supplementary information; 
Fig S1). Intrinsic disorder predisposition of TDP-
 at U
niversity of Southern M










43 and four other proteins (superoxide dismutase 1 
(SOD1), FUS, a cofilin-binding protein C9orf72, 
and polypeptides generated as a result of its intronic 
hexanucleotide expansions, and actin-binding 
profilin-1 (PFN1)), which are considered as the 
major drivers of ALS and FTLD pathogenesis, 
recently revealed significant levels of disorder 
among these proteins (63,64). Here, we set out to 
determine whether disorder and charge distribution 
among TDP-43 CTD, and GRNs indicate 
interaction propensities. The primary sequence of 
GRN-5 is enriched in negatively charged residues 
and lack positively charged residues with a net pI 
of 4.01. On the other hand, TDP-43 CTD has an 
appreciable number of positively charged amino 
acids with a net pI of 9.52 (Fig 1a). The computed 
disorder predispositions show high degree of 
disorder for entire sequence of TDP-43 CTD 
(values > 0.5; Fig 1b), while GRN-3 and GRN-5 
show disordered regions in both N- and C-terminal 
regions (Fig 1c and 1d). The linear net charge per 
residue (NCPR) plots for these proteins generated 
by CIDER computational platform (65) show that 
positively charged residues are preferentially 
concentrated within the 50 N-terminal residues of 
TDP-43 CTD (Fig 1e), whereas negatively charged 
residues are distributed over the entire sequence of 
GRN-5 (Fig 1g). Importantly, ANCHOR analysis 
(66,67)  of the TDP-43 CTD construct utilized in 
this study revealed the existence of several 
disorder-based binding regions (residues 1-40, 66-
99, 115-123, and 135-145). These regions represent 
molecular recognition features (MoRFs), which are 
intrinsically disordered segments that undergo 
folding on interaction with specific binding 
partners. Based on the counter-ionic character of 
the two proteins, we hypothesize that GRN-5 could 
interact with TDP-43 CTD and mediate LLPS. In 
addition, GRN-3 was chosen to test our hypothesis 
as this protein is also intrinsically disordered and 
has a pI of 5.33, but it contains both positive and 
negatively charged residues (Fig 1a and Fig 1f).  
We also checked the amino acid sequence-
based predispositions of TDP-43 CTD, GRN-3, and 
GRN-5 to undergo LLPS. To this end, the 
CatGRANULE algorithm was utilized that predicts 
LLPS propensity based on the analysis of the phase 
separation features linked to its primary sequence 
composition, structural disorder, and nucleic acid 
binding propensities (68). This analysis indicated 
that the CatGRANULE scores for TDP-43 CTD, 
GRN-3, and GRN-5 were 3.88, -3.06, and -2.83, 
respectively, indicating that only TDP-43 CTD has 
an intrinsic propensity for granule formation 
associated to liquid demixing under the 
physiological conditions. It has to be borne in mind 
that the positive CatGRANULE score for TDP-
43CTD can be attributed to the fact that the 
algorithm was trained on the TDP-43 sequence. 
However, the negative CatGRANULE scores for 
GRNs are independent and decoupled to the use of 
TDP-43 sequence for the algorithm training. 
GRN-5 but not GRN-3 initiates LLPS of TDP-
43 CTD. To see whether GRNs mediate TDP-43 
CTD phase separation, the two proteins were co-
incubated in 2:1 molar ratio respectively, and the 
samples were monitored for turbidity increase and 
droplet formation by differential interference 
contrast (DIC) microscopy in both oxidizing 
(GRN-3 or GRN-5) and reducing (rGRN-3 or 
rGRN-5) conditions (Fig 2). At room temperature, 
20 µM TDP-43 CTD buffered in 20 mM MES at 
pH 6.0 without salt in presence of 40 µM of GRN-
5 or rGRN-5 formed a turbid solution instantly, 
similar to the known phase separation shown by 
TDP-43 CTD-RNA mixture (Fig 2a). On the other 
hand, incubation of TDP-43 CTD by itself or with 
40 µM of GRN-3 or rGRN-3 did not show turbidity 
(Fig 2a). To define the phase boundaries of LLPS 
by TDP-43 CTD by under increasing GRN 
concentrations, 20  µM TDP-43 CTD was 
incubated with GRN-3, rGRN-3, GRN-5 and 
rGRN-5 in the absence of salt (Fig 2b). Both GRN-
5 and rGRN-5 induce LLPS at concentrations as 
low 10 µM while neither GRN-3 nor rGRN-3 failed 
to induce any LLPS even at high concentrations 
(Fig 2b). Next, phase boundaries of TDP-43 CTD 
LLPS as a function of GRN concentration and ionic 
strength were determined (Fig 2c-g). TDP-43 CTD 
control in the absence of GRNs but with increasing 
NaCl concentrations showed no LLPS below the 
physiological concentration of 150 mM salt (Fig 
2c). GRN-3 showed LLPS above 100 mM NaCl 
over a large GRN concentration range (Fig 2d). 
rGRN-3 showed LLPS under relatively a narrow 
range of salt concentrations above 300 mM (Fig 
2e). Both GRN-5 and rGRN-5 induced LLPS over 
a broad range of GRN and salt concentrations (Fig 
2f-g). Only low GRN concentration and low ionic 
strength failed to induce LLPS of TDP-43 CTD.     
To visualize LLPS, the samples were observed 
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under a DIC microscope for 2:1 co-incubations of 
GRN:TDP-43 CTD in the same buffer conditions 
as mentioned above. The TDP-43 CTD control 
along with the mixture containing GRN-3 or rGRN-
3 did not show the formation of liquid droplets for 
up to 6 hours (Fig 2h). In contrast, liquid droplets 
were observed almost instantaneously when TDP-
43 CTD was co-incubated with rGRN-5, GRN-5 or 
RNA (Fig 2h). The droplets that were numerous 
and small initially, grew in size by coalescing with 
one another in the next six hours of incubation, 
displaying fluid-like characteristics. Together, the 
data suggest GRN-5 or rGRN-5, and not GRN-3 or 
rGRN-3, is able to initiate/enhance the phase 
separation of TDP-43 CTD significantly at low salt 
concentrations.   
GRNs -3 and -5 differently modulate the LLPS 
and formation of ThT-positive aggregates of TDP-
43 CTD. In FTLD and ALS pathologies, TDP-43 
CTD is known to form toxic inclusions in the 
cytosol. Yet, ambiguity remains regarding the 
nature of these inclusions, with the presence of both 
thioflavin-T (ThT)-positive and ThT-negative 
aggregates has been reported (69-72). To see how 
GRNs affected the formation of TDP-43 CTD 
inclusions, we monitored ThT fluorescence for 
TDP-43 CTD samples in the presence of increasing 
concentrations of GRN-3, rGRN-3, GRN-5, or 
rGRN-5 at 37 °C (Fig 3). The sample of 20 µM 
TDP-43 CTD alone in 20 mM MES buffer at pH 
6.0 showed a typical sigmoidal increase in 
fluorescence with a lag time of ~ 8 hours (l; Fig 3) 
indicating the formation of ThT-positive species. 
For GRN-3 incubations, increasing its 
stoichiometry from 0.1 to 4-fold excess to that of 
TDP-43 CTD showed increasing lag time of 
aggregation (Fig 3a). The 0.1-fold incubation 
showed the smallest lag time with 12 hours, while 
the 4-fold excess GRN-3 showed the highest lag 
time of ~22 hours. Similarly, under fully reducing 
conditions, 0.1 to 4-fold excess of rGRN-3 also 
inhibited TDP-43 CTD aggregation, but to a much 
lesser degree than GRN-3, with lag times ranging 
between 8 and 15 hours (Fig 3b). Similarly, 
incubation of GRN-5 in increasing concentrations 
(0.1 to 4-fold excess) with TDP-43 CTD showed an 
overall inhibition of the TDP-43 CTD fibrillation 
by increasing the lag times (12 to 36 hours, 
respectively) (Fig 3c). Incubations of rGRN-5 with 
TDP-43 CTD, on the other hand, showed no 
discernable lag time but an instantaneous linear 
increase in ThT fluorescence for all stoichiometric 
incubations (Fig 3a; inset). These data suggest that 
GRN-3 and GRN-5 interact with TDP-43 CTD 
differently to modulate latter’s aggregation. 
Furthermore, the observed instantaneous LLPS of 
TDP-43 CTD in the presence of GRN-5 and rGRN-
5 (Fig 2) raises the possibility of the ThT dye 
partitioning into the droplets formed, resulting in 
the higher ThT fluorescence observed. To 
investigate this, the reactions were visualized by 
fluorescence microscopy using another amyloid 
binding dye called thioflavin-S (ThS). Both ThT 
and ThS are known to detect amyloid aggregates 
(73,74). A 10 µM buffered solution of ThS was 
added to the samples containing 20 µM TDP-43 
CTD alone (Fig 3i) and in the presence of 40 µM 
GRNs; GRN-3 (Fig 3e), rGRN-3 (Fig 3f), GRN-5 
(Fig 3g), and rGRN-5 (Fig 3h). Instantaneously 
upon addition, TDP-43 CTD alone and with either 
GRN-3 or rGRN-3 showed no aggregate formation, 
and a disperse blue fluorescent haze was observed 
(Fig 3i , Fig 3e and Fig 3f; 0h). It has to be noted 
that the use of a 420-480 nm band pass emission 
filter generates a blue color to ThS. The same 
reactions after 36 hours showed more concentrated 
areas where ThS was observed that coincided with 
the presence of inclusions (Fig 3i, Fig 3e and Fig 
3f; 36h). GRN-5 or rGRN-5 on the other hand, 
showed the presence of ThS within the droplets 
even at 0 hours (Fig 3g and Fig 3h; 0h), which 
continued to be present even after 36 hours (Fig 3g 
and Fig 3h; 36h). These data suggest that, a) ThS 
(or ThT) could partition into the droplets, b) 
enhanced fluorescent signals could emerge due to 
partitioning into the droplets, and c) a small amount 
of ThT-positive species could be present within the 
droplets.  
Both GRNs colocalize with TDP-43 CTD 
within the droplets or aggregates. To probe 
whether the droplets are complex coacervates of 
TDP-43 CTD and GRNs or formed without GRNs’ 
partitioning into the separated phase, fluorescence 
microscopy was used to observe the colocalization 
of the two proteins. TDP-43 CTD and GRNs, 
labeled with HiLyte 647 and HiLyte 405, 
respectively, were incubated separately under 
oxidizing and reducing condition and monitored for 
36 hours (Fig 4). As expected, TDP-43 CTD by 
itself did not form phase separated droplets 
immediately after incubation (Fig 4a; 0h), and over 
the next 36 hours, sparse deposits of aggregated 
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protein were observed (Fig 4a; 18h and 36h). Co-
incubations of GRN-3 or rGRN-3 with TDP-43 
CTD showed no LLPS immediately after 
incubation (Fig 4b and Fig 4c; 0h), parallel to the 
observation by DIC and turbidity (Fig 2). Even 
after 36 hours, no phase separated liquid droplets, 
but insoluble, fibrillar deposits were observed (Fig 
4b and Fig 4c; 18h and 36h) that bind amyloid dyes 
as shown above (Fig 3). Moreover, the GRNs were 
observed to be localized in the vicinity of TDP-43 
CTD deposits as well as within them (Fig 4b and 
Fig 4c; 36h). On the other hand, co-incubations of 
both GRN-5 and rGRN-5 with TDP-43 CTD 
resulted in the emergence of well-defined liquid 
droplets immediately after incubation (Fig 4d and 
Fig 4e; 0h). The number of droplets increased 
during the next 36 hours of incubation, with some 
becoming more distorted spherical droplets (Fig 4d 
and Fig 4e; 18h and 36h). Importantly, both GRNs 
(blue) colocalize within the droplets formed by 
TDP-43 CTD (red). To further glean into the 
physical nature of the droplets or insoluble 
inclusions formed, fluorescence recovery after 
photobleaching (FRAP) was conducted (Fig 4f-j). 
After 36h of incubation, TDP-43 CTD control 
showed no recovery after bleaching indicative of 
insoluble solid nature of the aggregates (Fig 4f). A 
similar behavior was observed with the 
coincubations of TDP-43 CTD with GRN-3 or 
rGRN-3 (Fig 4g and 4h) suggesting that GRN-3 in 
both reducing and oxidized states promoted 
insoluble fibrils of TDP-43 CTD as seen from the 
microscopy images. However, GRN-5 in both 
redox states (GRN-5 and rGRN-5) showed 
exponential fluorescence recovery immediately 
after incubation indicating fluid property of the 
droplet (Fig 4i and 4j; 0h). After 36h, the extent of 
recovery was slightly mitigated indicating a 
possible “gelation” of the droplet (Fig 4i and 4j; 
36h). Together, the data further confirm that both 
GRN-5 and rGRN-5 induce LLPS with TDP-43 
CTD by coacervation. On the other hand, GRN-3 
does not induce LLPS but forms insoluble deposits 
of aggregated forms of TDP-43 CTD, indicating the 
differential specificity for the two GRNs in 
interacting with TDP-43 CTD. In other words, both 
GRNs could initiate different biophysical 
processes; while the presence of GRN-3 or rGRN-
3 lead to insoluble aggregates, those of GRN-5 or 
rGRN-5 result in the droplet formation that could 
change to gelation or aggregates over time.  
To further confirm and quantify the partitioning 
and co-localization of TDP-43 CTD and GRNs, the 
relative amounts of the proteins within the droplets 
as well as the deposits were quantified by MALDI-
TOF mass spectrometry. Using a known amount of 
insulin (6.45 ng/µL) as an external standard, the 
mass spectra were obtained (Figs 5a-e) and the 
relative quantities of the proteins were calculated 
and normalized (detailed in Materials and 
Methods). Aliquots of the samples used in Fig 3 and 
Fig 4 were obtained after 36 hours for quantitative 
analysis. Both GRN-3 and rGRN-3 showed positive 
correlation between the amount of GRN co-
incubated and TDP-43 CTD with the amount of 
GRN-3 or rGRN-3 increasing in the sedimented 
pellet with increase in GRN:TDP-43 CTD molar 
ratios (Fig 5f and Fig 5g). More importantly, the 
ratio of GRN to TDP-43 CTD intensities remained 
below one, suggesting GRN-3 or rGRN-3 may 
augment TDP-43 CTD aggregation by nucleating 
and not by forming a co-complex in stochiometric 
proportions. This observation is similar to the 
recently observed ability of GRN-3 and rGRN-3 to 
form fibrils of amyloid-b(1-42) (Ab42) peptide 
involved in Alzheimer disease (AD), where 
minimal GRN was observed in the pellet (58). On 
the other hand, the ratio of GRN-to-TDP-43 CTD 
obtained from the sedimented droplets of TDP-43 
CTD and GRN-5 or rGRN-5 co-incubations did not 
show a linear increase with increasing 
concentrations of GRN as observed with GRN-3 
(Fig 5h and Fig 5i). For co-incubations of GRN-5 
and rGRN-5, the GRN-to-TDP-43 CTD ratio 
remained at 0.75 and 1.1, respectively, over the 
entire range of molar ratios. It is known that the 
phenomenon of coacervation is dependent on a 
defined valency of interactions among the 
molecules which remain fixed within the dense 
phase (75-78). One could speculate that the network 
of weak interactions necessary to stabilize the TDP-
43 CTD droplets could be achieved by 
accommodating equimolar proportions of GRN-5 
or rGRN-5 within the droplets.  
GRNs modulate liquid droplets formed by 
TDP-43 CTD and RNA. One of the main aspects of 
TDP-43 pathobiology is the coacervation with 
RNA molecules to form membraneless organelles 
in the form of stress granules (79-81). To see 
whether GRNs 3 and 5 are able to interact with, and 
modulate liquid droplets (LDs) of TDP-43 CTD 
and RNA, torula yeast RNA extract was co-
 at U
niversity of Southern M










incubated with TDP-43 CTD in the presence or 
absence of GRNs. As expected, control LDs 
containing a mixture of 20 µM TDP-43 CTD and 
40 µg/mL RNA showed high turbidity (Fig 6a). 
Solutions containing a mixture of LDs and 40 µM 
of GRN-5 showed an increase in turbidity as 
compared to LD control (Fig 6a). The sample 
containing 40 µM rGRN-5 and LDs did not show 
appreciable change in turbidity. Similarly, solutions 
containing a mixture of LDs and GRN-3 or rGRN-
3 showed a slight decrease or no change turbidity 
levels as compared to the control (Fig 6a). In order 
to see how GRNs affect the formation of ThT-
positive inclusions of the LDs, the reactions were 
monitored by ThT fluorescence (Fig 6b-c). As 
expected, the co-incubation of RNA with TDP-43 
CTD did not show any ThT increase as they form 
LDs (Fig 6b and Fig 6c) as compared to the TDP-
43 CTD alone (; Fig 6b and Fig 6c). Inclusion of 
rGRN-3 to the RNA and TDP-43 CTD mixture 
significantly increased the rate of ThT-positive 
aggregates of TDP-43 CTD (Fig 6b) but slightly 
delayed the aggregation compared to TDP-43 CTD 
alone or with rGRN-3 (Fig 6b). Similar 
augmentation of aggregation was observed with the 
co-incubation of GRN-3 and TDP-43 CTD-RNA 
mixture (Fig 6b) although the increase in rate of 
aggregation was less pronounced with GRN-3 as 
compared to rGRN-3 as previously observed in Fig 
3. Co-incubation of rGRN-5 to the TDP-43 CTD-
RNA mixture ‘rescued’ the aggregation of TDP-43 
CTD with a linear increase in ThT fluorescence 
observed within hours of incubation (Fig 6c). 
However, augmentation of ThT-positive aggregates 
was also pronounced with the co-incubation of 
GRN-5 (Fig 6c). These data indicate that GRNs are 
able to modify LD to promote aggregates of TDP-
43 CTD. 
To further understand the mechanism of GRNs’ 
influence on LD, co-incubations of fluorescently-
tagged samples were monitored by DIC 
microscopy. As expected, TDP-43 CTD-RNA 
showed LD formation immediately after incubation 
that remained for 36 hours (Fig 6d). Co-incubation 
of GRN-3 or GRN-3 with the mixture of TDP-43 
CTD and RNA showed neither a marked change to 
the droplet shape or size nor the GRN colocalized 
within the droplet (Fig 6e-f). After 36 hours, a 
marginal increase in LD size was observed with 
GRN colocalized within the droplets (Fig 6e-f). 
However, the samples showed distortions in the 
morphology of LDs accompanied by an overall 
reduction in the size during the course of the 
experiment (Fig 6e-f). Addition of GRN-5 to TDP-
43 CTD-RNA mixture also showed the formation 
of droplets immediately with GRN colocalized 
within the droplets, which fused and grew bigger in 
size during the next 36 hours, with both TDP-43 
CTD and GRN-5 colocalizing within the LDs (Fig 
6g). Addition of rGRN-5 to TDP-43 CTD-RNA 
mixture led to droplet formation which grew in 
number but not in size during the same time (Fig 
6h). rGRN-5 also co-localized with TDP-43 CTD 
within the LDs.  
To probe the internal dynamics of the LD 
droplets, FRAP was monitored temporally on 
labelled TDP-43 CTD in presence of RNA and 
GRNs. The fluorescence recovery rates for the 
control LDs formed by TDP-43 CTD and RNA 
showed near identical rates at both 0 and 36 hours, 
indicating preservation of internal mobility and 
dynamism over the incubation period (Fig 6i). LDs 
formed in the presence of either GRN-3 or rGRN-3 
showed a marked level of decrease in the internal 
mobility of the droplets during the 36 hours of 
incubation (Fig j-k). Similarly, LDs formed in 
presence of both redox forms of GRN-5 displayed 
a decreased fluorescence recovery after 36 hours 
indicating an inhibition of internal mobility, which 
could indicate the maturation of the droplets into 
gels, process commonly known as ‘gelation’ (Fig 
6l; GRN5 and Fig 6m; rGRN-5). Similar to the 
observation of GRN-5 and TDP-43 CTD where 
‘gelated’ droplets eventually transition to solid 
aggregates (Fig S2), it is possible that these 
‘gelated’ LD also eventually form insoluble 
aggregates of TDP-43 CTD. The increase in ThT 
fluorescence (Fig 6c) can be explained by the fact 
that ThS (and likely ThT) is able to partitions into 
the droplets and fluoresces as observed (Fig 3). The 
results obtained suggest that both GRNs 3 and 5 in 
redox conditions co-localize and stabilize the LDs 
formed by TDP-43 CTD and RNA.  What cellular 
ramifications this may have on stress response by 
stress granules is remains to be seen.  
 
DISCUSSION 
Link between PGRN and familial FTLD/ALS 
is well-established with the implication of 
autosomal dominant mutations in PGRN, which 
leads to the protein’s haploinsuffiency. The loss of 
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PGRN function in these pathologies is also 
speculated to arise at a posttranscriptional level 
with increased PGRN proteolysis (82). GRN 
immunopositivities have indeed been observed in a 
region-specific manner in both AD and FTLD 
human brains (83). Furthermore, the production of 
GRNs in haploinsufficient and not null state in 
familial FTLD suggests that they may be key 
players in the disease phenotypes. Support for this 
thought comes from the observation that GRNs 
interact with TDP-43 and exacerbate latter’s levels 
and toxicity in C.elegans (57). Moreover, the recent 
discovery of PGRN/GRNs being associated with 
lysosomal dysfunction (84) also posits the question 
whether GRNs could be involved in autophagic fate 
of TDP-43 inclusions under redox stress. The 
results presented here attempts to answer some of 
the key questions regarding GRNs and TDP-43 
CTD such as how GRNs modulate the dynamics 
between LD and fibril formation of TDP-43 CTD 
and do LDs facilitate the formation of insoluble 
TDP-43 CTD inclusions.  
The findings of this study showcase how GRNs 
-3 and -5 modulate the dynamics of TDP-43 CTD 
in forming insoluble aggregates or LDs in both 
oxidizing and reducing conditions. It is clear from 
the data that GRN-3 and GRN-5 affect TDP-43 
CTD aggregation via disparate mechanisms; while 
GRN-3 induces the formation of insoluble 
inclusions, GRN-5 coacervates with TDP-43 CTD 
to undergo LLPS in both reduced and oxidized 
forms, an interaction which is likely to be driven by 
the counter-ionic electrostatic characteristics of 
TDP-43 CTD and the negatively charged GRN-5 
(85-87). Furthermore, GRN-3 and GRN-5 also 
modify LDs formed by the coacervation of RNA 
and TDP-43 CTD. Specifically, GRN-3 in both 
redox states accelerate the formation of ThT-
positive, insoluble aggregates of TDP-43 CTD. 
This observation supports the one by Salazar and 
co-workers who observed exacerbation of TDP-43 
toxicity in C.elegans by GRN-3 and GRN-7 (57). 
GRN-5, on the other hand seems to remodify the 
LDs by inducing gelation within the 36-hour time 
period, which changes to fibril formation after 
extended time period (supplementary Fig S2). At 
this point, it is unclear as to what cellular 
ramifications do the gelation of LDs by GRN-5 
have, but our on-going investigations will glean 
into this aspect in the future. Nevertheless, our 
results provide the first in vitro evidence for an 
interaction between GRN and TDP-43 CTD.  
The increasing relevance of GRNs in FTLD 
and associated neurodegenerative disorders imparts 
significance to the results presented in this study. 
Despite its significance, how haploinsufficiency of 
PGRN results in TDP-43 inclusions in FTLD and 
ALS patients remains unknown. Common 
mutations associated with PGRN 
haploinsufficiency have been linked to mutant 
mRNA degradation (88) which several groups have  
identified leads directly to reduced circulating 
levels of PGRN (89-91). A few have also argued 
that increased proteolysis of PGRN as the reason 
for haploinsufficiency, which leads to increase in 
GRN levels  (57). A more recent study established 
that more effective proteolytic processing of 
cathepsin D, an aspartyl protease that is known to 
cleave PGRN, occurs in the presence of GRNs (92), 
which seem to support the idea that generation of 
GRNs to be the reason for decreased availability of 
PGRN. Results presented in this study identify a 
potential mechanism by which GRNs interact with 
TDP-43 CTD and modulate the latter’s ability to 
aggregate and/or phase separate (Fig 6). Based on 
our data we can hypothesize that the selective 
GRNs interact with free TDP-43 CTD to augment 
its aggregation and potentially its cytotoxicity. 
Alternatively, under redox stress, GRNs can 
interact with LDs to modulate the dynamics within 
the droplets towards the formation of insoluble 
inclusions or lead to a decreased stress response. 
These aspects, along with whether and how these 
processes are regulated by phosphorylation and 
other mutations within GRNs and TDP-43 are 
currently being investigated in our laboratory, and 
the results obtained will be reported at a later time. 
    
EXPERIMENTAL PROCEDURES 
Expression and purification of recombinant 
proteins 
Granulins (GRN-3 & GRN-5): Unlabeled 
GRN-3 was expressed and purified from E. coli 
SHuffleTM cells (New England Biolabs) as 
described previously (62), while unlabeled GRN-5 
and 15N labeled GRN-5 were expressed in Origami 
2 DE3 (Invitrogen). Briefly, the proteins were 
expressed as a GRN:trxA fusion construct and 
purified using immobilized-nickel affinity 
chromatography. The fusion protein was then 
cleaved by addition of restriction grade thrombin 
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(Bovine, BioPharm Laboratories) at 1U per 1 mg of 
the protein to remove both trxA and the His-tag. 
The reaction was incubated at room temperature 
(~25°C) for 22-24 hours. The protein was then 
fractionated on a semi-preparative Jupiter® 5 μm 
10x250 mm C18 reverse phase HPLC column 
(Phenomenex), using a gradient elution of 60 – 80 
% acetonitrile containing 0.1% TFA as previously 
described (62). The concentration of the proteins 
was estimated spectrophotometrically using molar 
extinction coefficients of 6250 M-1cm-1 for GRN-3 
and 7740 M-1cm-1 for GRN-5 at 280 nm. The 
number of free cysteines was calculated from 
Elman’s assay and by iodoacetamide labeling as 
previously reported (62). rGRN-3 and rGRN-5 
were generated by the addition of 2 mM Tris(2-
carboxyethyl)phosphine hydrochloride (TCEP) to 
the HPLC fractionated protein for 2 hours at room 
temperature and were used as the reduced form. 15N 
labeled GRN-3,5 were generated by growing the 
cells in M9 minimal media enriched with 15NH4Cl. 
TDP-43 CTD. The plasmid for the TDP-43 
CTD expression was a gift from Dr. Nicolas Fawzi 
at Brown University (Addgene plasmid # 98669; 
http://n2t.net/addgene:98669; RRID:Addgene 
98669). The protein was expressed as a fusion 
construct with a His-tag (His6) at the N-Terminal 
followed by a TEV cleavage site The plasmid was 
expressed in E.coli BL21 Star™ (DE3) cells (Life 
Technologies). Transformed cells were grown at 
37°C in LB medium supplemented with 100μg/ml 
of kanamycin. Overexpression of the protein was 
induced by adding isopropyl β-D-1-
thiogalactopyranoside (IPTG) to a final 
concentration of 0.5 mM at an optical density 
(O.D600) of 0.5-0.7 AU. After overnight induction 
at room temperature (~25°C), cells were harvested 
by centrifugation (15000xg, 4 °C) and used 
immediately or stored at −20°C. The cells were 
resuspended in lysis buffer (20 mM Tris pH 8.0, 
500 mM NaCl, 5 mM imidazole, 6 M urea). 0.5 mM 
phenylmethylsulfonyl fluoride (PMSF) was also 
added to the resuspension. Cells were lysed using 
Misonix XL-2000. The lysate was centrifuged at 
20000 xg, 4°C, for 1 hour to remove cellular debris. 
The supernatant was incubated with Ni-NTA resin 
at 4°C for 2 hours. The slurry was resuspended in 
Kimble Kontes Flex column and washed with wash 
buffers (20 mM Tris pH 8.0, 500 mM NaCl, 6 M 
Urea) of 15 mM and 30 mM imidazole and protein 
was eluted in elution buffer (20 mM Tris pH 8.0, 
500 mM NaCl, 6 M Urea, 150 mM imidazole). 
Eluate was buffer exchanged into storage buffer (20 
mM Tris pH 8.0, 500 mM NaCl, 2 M Urea) and 
concentrated using Amicon Ultra-Centrifugal units 
(Millipore). Concentrated protein was flash frozen 
and stored at -80°C. Concentrated aliquots were 
thawed on ice and desalted into 20 mM MES pH 
6.0 using Zeba Desalting Spin Columns (Thermo) 
and used as such for studies.  
 
Thioflavin-T fluorescence  
The aggregation kinetics of TDP-43 CTD were 
monitored using Thioflavin-T (ThT) on a BioTek 
Synergy H1 microplate reader. 20 μM TDP-43 
CTD under varying reaction conditions was 
incubated at 37°C for 36 hours in presence of 10 
μM ThT. Samples were excited at 440 nm and 
emission was monitored at 480 nm. The ThT 
kinetic data was fit using the Boltzmann function 
on Origin 8.5. 
 
MALDI-ToF mass spectrometry 
    Pellet and droplet characterization of the co-
incubated protein complexes was performed on a 
Bruker Datonics Microflex LT/SH ToF-MS 
system. Samples from aggregation kinetic reactions 
were recovered after a period of 36 hours. The 
recovered samples were spun down at 18000 xg and 
supernatant was decanted. The pellet obtained was 
then resuspended in equal volume of reaction buffer 
(20 mM MES, pH 6.0). The pellet and supernatant 
fractions were then prepared for MALDI-MS by 
mixing with 6.5 ng of insulin (external standard). 
Additionally, the pellet samples were dissolved 
with formic acid in a 1:1 ratio to allow 
disaggregation of fibrils and other insoluble 
complexes. Both aliquots were then spotted onto a 
Bruker MSP 96 MicroScout Target with 1:1 ratio of 
sample:sinapinic acid matrix in saturated 
acetonitrile and water. Instrument calibration was 
performed using Bruker Protein Calibration 
Standard I (Bruker Daltonics). 
 
Differential Interference Contrast (DIC)  
The phase separation was monitored using DIC 
on a Leica DMIL LED microscope under 20x or 
40x magnification with a DIC polarizing filter. The 
reactions were observed on a clear-bottom Nunc™ 
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For colocalization studies of GRNs and TDP-
43 CTD during the course of their interactions, 
labeling of the respective proteins with amine-
reactive fluorescent dyes was performed and 
visualization was done on a Zeiss LSM 510 Meta 
confocal microscope at 40x or 63x magnification 
under oil-immersion with a DIC polarizing filter. 
Briefly, TDP-43 CTD was labelled with HiLyte-
647 (AnaSpec) and GRN-3,5 were labelled with 
HiLyte-405 (AnaSpec). Free dyes were removed 
via the use of desalting columns; Zeba Desalting 
Spin Columns (Thermo) for labeled TDP-43 CTD 
and Clarion™ MINI Spin Columns, Desalt S-25 
(SorbTech) for labeled GRN-3,5. 20 uM TDP-43 
CTD was mixed with 40 μM GRN-3,5 or 40 ug/mL 
of RNA. A ratio of 1% Labeled: 99% Unlabeled 
proteins was used for both TDP-43 CTD and 
GRNs. Reactions were performed on the following 
experimental setup: A glass cover-slip was attached 
onto one end of a two-side open ended 96 well plate 
(Greiner Bio-One). Reactions were loaded into a 
well and covered with an optically clear plate-
sealing film (Thermo). Reactions were then 
monitored at certain timepoints. Similarly, for 
observing the localization of ThS, 10 μM ThS 
(AAT bioquest) was added to sample containing 20 
μM TDP-43 CTD with 40 µM of GRNs. Samples 
were visualized using the setup described above on 




FRAP assays were performed in open-ended 96 
well plates as described above; 10 μM TDP-43 
CTD was mixed with 20 μM GRN-3,5 or 20 μg/mL 
of RNA. Reactions were monitored 10 mins after 
mixing to allow deposition of suitable droplets onto 
the bottom of the well, which were used for 
bleaching. TDP-43 CTD labelled with HiLyte-647 
(AnaSpec) was used as the probe in the assays. 
LSM 510 Meta confocal microscope at 63x 
magnification under oil-immersion with a DIC 
polarizing filter and FRAP module. The region of 
interest was bleached with 633 nm laser line with 
100% bleaching intensity for 750 iterations and 
imaging was performed at 5% laser intensity for 
120 secs after bleaching. Numerical aperture was 
kept at 0.69 AU. 
 
NMR spectroscopy  
The HMQC NMR spectra for 20 μM 15N GRN-
5 or rGRN-5 resuspended in 20 mM MES (pH 6.0) 
with 10% D2O was acquired on a Bruker Advance 
– III-HD 850 MHz NMR spectrometer equipped 
with a Bruker TCI cryoprobe at the high field NMR 
facility of University of Alabama, Birmingham as 
described previously(62).  
 
Computational analysis of TDP-43 CTD, GRN-3, 
and GRN-5 
Per-residue intrinsic disorder predispositions of 
TDP-43 CTD, GRN-3, and GRN-5 were evaluated 
by a set of commonly used disorder predictors, such 
as PONDR® VLXT(93) , PONDR® VSL2 (94) , and 
PONDR® VL3 (95)  available on the PONDR site 
(http://www.pondr.com) PONDR® FIT (96) 
accessible at the DisProt site 
(http://original.disprot.org/metapredictor.php), and 
the IUPred computational platform available at 
IUPred2A site (https://iupred2a.elte.hu/) that 
allows identification either short or long regions of 
intrinsic disorder, IUPred-L and IUPred-S (97-
100). For each query protein, the outputs of these 
individual predictors were used to calculate a 
consensus disorder profile by averaging disorder 
profiles of individual predictors. The outputs of 
these tools are represented as real numbers between 
1 (ideal prediction of disorder) and 0 (ideal 
prediction of order). A threshold of ≥0.5 was used 
to identify disordered residues and regions in query 
proteins. A protein region was considered flexible, 
if its disorder propensity was in a range from 0.2 to 
0.5. Results of this multiparametric computational 
analysis are presented in a form of mean disorder 
propensity calculated by averaging disorder 
profiles of individual predictors. Use of consensus 
for evaluation of intrinsic disorder is motivated by 
empirical observations that this approach usually 
increases the predictive performance compared to 
the use of a single predictor (96,101-108). CIDER 
computational platform (65) was used to generate 
linear net charge per residue diagrams for query 
proteins, whereas the sequence-based propensities 
of TDP-43 CTD, GRN-3, and GRN-5 for granule 
formation associated to liquid demixing under the 
physiological conditions were evaluated by 
CatGRANULE algorithm (68) , which generates 
positive and negative scores for proteins capable 
and not capable of granule formation, respectively. 
Finally, the presence of disorder-based binding 
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sites in TDP-43 CTD was evaluated by the 
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Fig 1:  Sequence, disorder and charge distributions of the proteins used in this study. a) The 
sequence of TDP-43 C-terminal domain (TDP-43 CTD) (267-414; 14.5 kDa) which constitutes 
the major part of the toxic 25 kDa TDP-43 C-terminal fragment with a hexa histidine-tag on the 
N-terminus. Sequences of GRN-3 and GRN-5 with putative disulfide bonds. A conservative 
mutation of Y to W (indicated as *) was made to GRN-3, which is a conserved residue in all 
GRNs. Both GRNs were used in fully reduced (free thiols) and oxidized conditions in this study.  
Computational evaluation of the per-residue intrinsic disorder predispositions of TDP-43 CTD 
(b), GRN-3 (c), and GRN-5 (d).  Here, the outputs of PONDR® VLXT, PONDR® FIT, 
PONDR® VL3, PONDR® VSL2, IUPred_S and IUPred_L were averaged to generate mean 
disorder profiles of different computational data query proteins. Diagrams of linear net charge 
per residue (NCPR) for TDP-43 CTD (e), GRN-3 (f), and GRN-5 (g) generated by CIDER 
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Fig 2: TDP-43 CTD undergoes LLPS in the presence of both oxidized and reduced GRN-5. 
a) Visual snapshots immediately after the incubations of 20 µM TDP-43 CTD in 20 mM MES 
buffer pH 6.0 without salt at room temperature by itself or with 40 µM GRNs in oxidized (GRN-
3; GRN-5) and reduced (rGRN-3; rGRN-5) conditions along with the positive control with 40 
µg/mL RNA. Only incubations with GRN-5, rGRN-5 and RNA show a turbid solution indicating 
phase separation. b) DIC microscopy images for the same reactions monitored for 6 hours. TDP-
43 CTD by itself or with GRN-3/rGRN-3 shows the absence of liquid droplets which those with 
GRN-5 or rGRN-5 coalescence of the droplets to varying degrees similar to the positive control 
(with RNA) confirming LLPS. Scale bar represents 50 µm. c-h) Phase diagrams for TDP-43 CTD 
LLPS under various conditions. Phase boundary is represented by lines while grey box represents 
the conditions where LLPS was observed. c) LLPS of 20 µM TDP-43 CTD as a function of 
increasing GRN concentrations in the absence of salt. d-h) Phase diagrams for 20 µM TDP-43 
CTD as a function of increasing salt and GRN concentrations for GRN-3 (e), rGRN-3 (f), GRN-5 
(g) and rGRN-5 (h) along with control TDP-43 CTD in the absence of GRN (d). All phase 
diagrams were obtained from the turbidity of the reactions measured at 600 nm within ten minutes 
of incubation. The color gradient representing LLPS was generated by normalizing the absorbance 
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Fig 3: Modulation of TDP-43 CTD aggregation by GRNs. a-d) The aggregation kinetics of 
20µM TDP-43 CTD in 20 mM MES buffer pH 6.0 at 37 °C with varying molar equivalence (2 to 
80 µM) of GRN-3 (a), rGRN-3 (b), GRN-5 (c) and rGRN-5 (d), monitored by thioflavin-T (ThT) 
fluorescence. The inset shows the enlarged areas (boxed with dashed lines) highlighting the lag 
times during aggregation. The data was fitted to Boltzmann sigmoidal function. e-h) Localization 
of the aggregate-specific dye, thioflavin-S (ThS) observed by confocal fluorescence microscopy 
images on the 1:2 reaction samples of TDP-43 CTD:GRN from a-d immediately (0h) and after 36 
hours of incubation. (i) Images of TDP-43 CTD control from the reaction in (a). Scale bar 
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Fig 4: Coacervation of GRNs with TDP-43 CTD and dynamics of LLPS. Localization of TDP-
43 CTD and GRNs was monitored on a co-incubated mixture of the two proteins in 1:2 molar 
ratio. A mixture containing 0.2 µM (1%) aliquot of TDP-43 CTD labeled with HiLyte 647 
fluorescent tag and 20 µM unlabeled TDP-43 CTD in 20 mM MES buffer pH 6.0 at 37 °C, was 
co-incubated with a mixture of 40 µM GRNs containing 1% of respective proteins labeled with 
HiLyte 405 in separate reactions. Each of the co-incubated mixtures were visualized using DIC 
microscope. ‘Bf’ represents bright field in all the images. a) TDP-43 CTD control in the absence 
of GRNs shows formation of fibrillar structures after a period of 18 hours that increase in size after 
36 hours. TDP-43 CTD co-incubated with GRN-3 (b) or rGRN-3 (c) show colocalization within 
the inclusions as well as some peripheral localization. Co-incubated samples containing GRN-5 
(d) or rGRN-5 (e) show co-localization with TDP-43 CTD within droplets formed by LLPS. Scale 
bars in a-e represent 20 µm. f-j) Fluorescence recovery after bleaching (FRAP) performed using 
HiLyte 647 labeled-TDP-43 CTD. Arrow represents the time of bleaching. f) Aggregates formed 
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by TDP-43 CTD control show no fluorescence recovery after 36 hours. g-h) fluorescence recovery 
for samples containing GRN-3(g) or rGRN-3(h) immediately (0 h; black) or after 36 h of 
incubation (red). i-j) fluorescence recovery for samples containing GRN-5 (i) or rGRN-5 (j) 
immediately (0h; black) and after 36 h of incubation (red). The confocal images in the insets in f-




Fig 5: Quantitation of sedimented droplets and pellets from the co-incubations of TDP-43 
CTD and GRNs. The co-incubated samples of TDP-43 CTD and GRNs from figures 3 and 4 were 
sedimented at 18,0000xg for 20 minutes after 36 hours of incubation, and the pellets were 
quantified by MALDI-Tof mass spectrometry using insulin (6.45 ng/µL, m.w 5733.9 Da) as an 
external standard. The amounts of GRN-3 (mw 6367.3 Da), GRN-5 (mw 6015.7 Da) or TDP-43 
CTD (mw 17008.1 Da) within the pellets were determined with respect to the standard (detailed 
in Materials and Methods) and plotted as a ratio of GRN to TDP-43 CTD for the respective molar 
ratios. a-e) MALDI-ToF spectra of samples containing 20 uM TDP-43 CTD with 40 µM of GRN-
3 (a), rGRN-3 (b), GRN-5 (c), rGRN-5 (d) and TDP-43 CTD control (e) Theoretical and observed 
molecular weights are shown within and outside parentheses, respectively. f-i) Ratio of intensity 
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of GRNs present in complex with TDP-43 CTD in samples of varying molar ratios of the former 
shows an increase of GRN-3 (e) and rGRN-3 (f) within the complexes at higher molar ratios, while 
GRN-5 (g) and rGRN-5 (h) are present in a constant amount. GRN-5 forms a 1:1 complex with 
TDP-43 CTD in both redox forms; GRN-5 (0.73) and rGRN-5 (1.1) as indicated by the average 




Fig 6: Modulation of TDP-43 CTD-RNA LDs by GRNs. a) Turbidity measured at 600 nm within 
ten minutes of incubation for the co-incubated solutions of 20 µM TDP-43 CTD with 40 µM GRN-
3 or 5 (reduced and oxidized), in the presence or absence of 40 µg/mL of RNA (n=3).  b-c) 
Aggregation kinetics of 20µM TDP-43 CTD in 20 mM MES buffer pH 6.0 at 37 °C with 40 µM 
of GRN-3 (b) and GRN-5 (c) in both oxidized and reduced forms, and in presence or absence of 
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RNA (40 µg/mL) monitored by ThT fluorescence. The inset shows the enlarged areas (boxed with 
dashed lines) highlighting the lag times during aggregation. d-h) Localization of the protein from 
the reactions similar to those in panels b and c visualized by labeling TDP-43 CTD and GRNs with 
HiLyte 647 and HiLyte 405, respectively (as it was done for Fig 4), and in the presence and absence 
of unlabeled RNA by DIC microscopy. Control sample containing TDP-43 CTD and RNA shows 
LDs (d). GRN-3 (e) or rGRN-3 (f) do not localize within LDs but form solid inclusions but GRN-
5 (g) or rGRN-5 (h) colocalize within the LDs. Scale bars in d-h represent 20 µm. j-m) FRAP data 
using HiLyte 647-labeled TDP-43 CTD with LDs and GRNs immediately after incubation (0 h; 
black) and after 36 hours (red). Arrow represents the time of bleaching. Fluorescence recovery for 
samples containing control LDs(i), GRN-3(j), rGRN-3(k), GRN-5 (l) or rGRN-5 (m). The insets 
in i-m show confocal images of the area bleached before, after, and after the recovery from left to 
right. Scale bar represents 2 µm. 
 
 
Fig 7: Schematic of the data presented in this study. GRNs selectively modulate the dynamics 
of TDP-43 CTD aggregation or phase separation, which may have physiological implications. The 
question marks indicate in this figure are possibilities unexplored in this manuscript.  
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